Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0760
J

Failure to Prevent Significant Medication Error: Missed Immunosuppressant Doses

Taunton, Massachusetts Survey Completed on 05-13-2025

Penalty

Fine: $342,260
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

A resident with a history of heart transplant, heart failure, and stroke was readmitted to the facility following a hospitalization for heart failure exacerbation. Upon discharge from the hospital, the resident was prescribed tacrolimus, an immunosuppressant medication, with a revised dosing schedule. The facility's medication reconciliation process identified potential clinically significant medication issues, but the documentation did not specify the discrepancies or their resolutions. An order for tacrolimus was entered into the physician's orders but was subsequently discontinued the same day, resulting in the resident not receiving any tacrolimus from the following day until nearly three weeks later. During this period, the resident missed 40 doses of tacrolimus. Progress notes and medication records failed to document the discontinuation or provide a rationale for stopping the medication. Multiple staff, including the physician and physician assistant, did not identify the omission of tacrolimus in the resident's regimen, despite reviewing the medication list and being aware of the resident's transplant status. The facility's pharmacy consultant also reviewed the medication regimen during this time and did not note any irregularities. Communication breakdowns were evident, as the resident's cardiology team repeatedly attempted to obtain updated medication lists and lab results from the facility but encountered significant barriers and delays. The error was ultimately discovered when the cardiology team noted a critically low tacrolimus level and contacted the facility, at which point it was confirmed that the resident had not received the medication. The resident required emergent hospitalization for rejection surveillance and medication adjustments. Interviews with facility staff revealed a lack of awareness regarding the discontinuation of tacrolimus and a failure to identify or address the medication error until notified by the external cardiology team.

An unhandled error has occurred. Reload 🗙